 SOUTH SAN FRANCISCO, Calif., Jan. 05, 2021 GLOBE NEWSWIRE -- Annexon, Inc. Annexon Nasdaq: ANNX, a clinical stage biopharmaceutical company developing a pipeline of novel therapies for patients with classical complement-mediated autoimmune and neurodegenerative disorders of the body, brain and eye, today announced that a corporate update will be presented at the 39th Annual J.P. Morgan Healthcare Conference on January 12, 2021 at 4:30pm ET. 